Salusin-α mitigates diabetic nephropathy via inhibition of the Akt/mTORC1/p70S6K signaling pathway in diabetic rats

References

• Brenneman, J., Hill, J., and Pullen, S., 2016. Emerging therapeutics for the treatment of diabetic nephropathy. Bioorganic and Medicinal Chemistry Letters, 26 (18), 4394–4402.
   PubMed Web of Science ®Google Scholar
• Cakir, M., 2017. Protective effects of salusin-alpha and salusin-beta on renal ischemia/reperfusion damage and their levels in ischemic acute renal failure. Biotechnic and Histochemistry, 92 (2), 122–133.
   PubMed Web of Science ®Google Scholar
• Chen, Y.J., et al., 2019. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomedicine and Pharmacotherapy, 111, 1166–1175.
   PubMed Web of Science ®Google Scholar
• Citil, C., et al., 2014. Brain, liver, and serum salusin-alpha and -beta alterations in Sprague-Dawley rats with or without metabolic syndrome. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 20, 1326–1333.
   PubMed Web of Science ®Google Scholar
• Esfahani, M., et al., 2017. Salusin-alpha attenuates inflammatory responses in vascular endothelial cells. Biochemistry (Moscow), 82 (11), 1314–1323.
   PubMed Web of Science ®Google Scholar
• Fineberg, D., Jandeleit-Dahm, K.A., and Cooper, M.E., 2013. Diabetic nephropathy: diagnosis and treatment. Nature Reviews Endocrinology, 9 (12), 713–723.
   PubMed Web of Science ®Google Scholar
• Gao, S., et al., 2018. Salusin-alpha inhibits proliferation and migration of vascular smooth muscle cell via Akt/mTOR signaling. Cellular Physiology and Biochemistry, 50 (5), 1740–1753.
   PubMed Web of Science ®Google Scholar
• Giacco, F., and Brownlee, M., 2010. Oxidative stress and diabetic complications. Circulation Research, 107 (9), 1058–1070.
   PubMed Web of Science ®Google Scholar
• Hao, H.H., et al., 2012. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sciences, 91 (19/20), 959–967.
   PubMed Web of Science ®Google Scholar
• Hers, I., Vincent, E.E., and Tavaré, J.M., 2011. Akt signalling in health and disease. Cellular Signalling, 23 (10), 1515–1527.
   PubMed Web of Science ®Google Scholar
• Huang, S., et al., 2019. Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway. Journal of Cellular Physiology, 234 (7), 11200–11207.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., et al., 2018. Diosmetin attenuates Akt signaling pathway by modulating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB)/inducible nitric oxide synthase (iNOS) in streptozotocin (STZ)-induced diabetic nephropathy mice. Medical Science Monitor, 24, 7007–7014.
   PubMed Web of Science ®Google Scholar
• Kashihara, N., et al., 2010. Oxidative stress in diabetic nephropathy. Current Medicinal Chemistry, 17 (34), 4256–4269.
   PubMed Web of Science ®Google Scholar
• Kimoto, S., et al., 2010. Serum levels and urinary excretion of salusin-alpha in renal insufficiency. Regulatory Peptides, 162 (1–3), 129–132.
   PubMedGoogle Scholar
• Kolakowska, U., Olanski, W., and Wasilewska, A., 2016. Salusins in hypertension and related cardiovascular diseases. Current Drug Metabolism, 17 (8), 827–833.
   PubMed Web of Science ®Google Scholar
• Lin, Y.C., et al., 2018. Update of pathophysiology and management of diabetic kidney disease. Journal of the Formosan Medical Association = Taiwan yi Zhi, 117 (8), 662–675.
   PubMed Web of Science ®Google Scholar
• Liu, Y., 2010. New insights into epithelial-mesenchymal transition in kidney fibrosis. Journal of the American Society of Nephrology, 21 (2), 212–222.
   PubMed Web of Science ®Google Scholar
• Liu, Y.W., et al., 2013. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. European Journal of Pharmacology, 721 (1–3), 355–364.
   PubMed Web of Science ®Google Scholar
• Liu, Y.W., et al., 2016. Ibuprofen attenuates nephropathy in streptozotocininduced diabetic rats. Molecular Medicine Reports, 13 (6), 5326–5334.
   PubMed Web of Science ®Google Scholar
• Liu, Y.W., et al., 2018. Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats. Phytotherapy Research, 32 (8), 1574–1582.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2019. Silibinin ameliorates diabetic nephropathy via improving diabetic condition in the mice. European Journal of Pharmacology, 845, 24–31.
   PubMed Web of Science ®Google Scholar
• Lu, J., et al., 2018. Trichosanthes kirilowii lectin alleviates diabetic nephropathy by inhibiting the LOX1/NF-kappaB/caspase-9 signaling pathway. Bioscience Reports, 38 (5), BSR20180071.
   PubMed Web of Science ®Google Scholar
• Lu, Q., et al., 2015a. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy. Pharmacological Research, 99, 237–247.
   PubMed Web of Science ®Google Scholar
• Lu, Q., et al., 2015b. Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy. Phytomedicine, 22 (12), 1071–1078.
   PubMed Web of Science ®Google Scholar
• Parveen, A., Jin, M., and Kim, S.Y., 2018. Bioactive phytochemicals that regulate the cellular processes involved in diabetic nephropathy. Phytomedicine, 39, 146–159.
   PubMed Web of Science ®Google Scholar
• Qian, K., et al., 2018. Overexpression of salusin-alpha inhibits vascular intimal hyperplasia in an atherosclerotic rabbit model. BioMed Research International, 2018, 1, 9.
   Web of Science ®Google Scholar
• Raptis, A.E., and Viberti, G., 2001. Pathogenesis of diabetic nephropathy. Experimental and Clinical Endocrinology and Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association, 109(Suppl 2), S424–S437.
   PubMed Web of Science ®Google Scholar
• Sagoo, M.K., and Gnudi, L., 2018. Diabetic nephropathy: is there a role for oxidative stress? Free Radical Biology and Medicine, 116, 50–63.
   PubMed Web of Science ®Google Scholar
• Sahin, I., and Aydin, S., 2013. Serum concentration and kidney expression of salusin-alpha and salusin-beta in rats with metabolic syndrome induced by fructose. Biotechnic and Histochemistry, 88 (3/4), 153–160.
   PubMed Web of Science ®Google Scholar
• Shah, I.M., Mackay, S.P., and McKay, G.A., 2009. Therapeutic strategies in the treatment of diabetic nephropathy – a translational medicine approach. Current Medicinal Chemistry, 16 (8), 997–1016.
   PubMed Web of Science ®Google Scholar
• Shichiri, M., et al., 2003. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nature Medicine, 9 (9), 1166–1172.
   PubMed Web of Science ®Google Scholar
• Shlipak, M., 2010. Diabetic nephropathy: preventing progression. BMJ Clinical Evidence, 2010, 0606.
   PubMedGoogle Scholar
• Shrestha, A., Che, R.C., and Zhang, A.H., 2019. Role of aldosterone in renal fibrosis. Advances in Experimental Medicine and Biology, 1165, 325–346.
   PubMed Web of Science ®Google Scholar
• Sidorenkov, G., and Navis, G., 2014. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opinion on Drug Safety, 13 (10), 1383–1395.
   PubMed Web of Science ®Google Scholar
• Sun, H.J., 2019. Current opinion for hypertension in renal fibrosis. Advances in Experimental Medicine and Biology, 1165, 37–47.
   PubMed Web of Science ®Google Scholar
• Sun, H.J., et al., 2014. Superoxide anions in the paraventricular nucleus mediate cardiac sympathetic afferent reflex in insulin resistance rats. Acta Physiologica, 212 (4), 267–282.
   PubMed Web of Science ®Google Scholar
• Sun, H.J., et al., 2017. Salusin-beta is involved in diabetes mellitus-induced endothelial dysfunction via degradation of peroxisome proliferator-activated receptor gamma. Oxidative Medicine and Cellular Longevity, 2017, 1.
   Web of Science ®Google Scholar
• Sun, Y.M., et al., 2013. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochemical and Biophysical Research Communications, 433 (4), 359–361.
   PubMed Web of Science ®Google Scholar
• Tang, K., et al., 2018. Salusin-alpha attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low-density lipoprotein receptor deficient mice. European Journal of Pharmacology, 830, 76–86.
   PubMed Web of Science ®Google Scholar
• Tanyeli, A., et al., 2017. Protective effect of salusin-α and salusin-β against ethanol-induced gastric ulcer in rats. Journal of Basic and Clinical Physiology and Pharmacology, 28 (6), 623–630.
   PubMedGoogle Scholar
• Wang, J., et al., 2017. Tetrahydrobiopterin contributes to the proliferation of mesangial cells and accumulation of extracellular matrix in early-stage diabetic nephropathy. Journal of Pharmacy and Pharmacology, 69 (2), 182–190.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2018. CTRP6 inhibits cell proliferation and ECM expression in rat mesangial cells cultured under TGF-beta1. Biomedicine and Pharmacotherapy, 97, 280–285.
   PubMed Web of Science ®Google Scholar
• Watanabe, T., et al., 2008. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation, 117 (5), 638–648.
   PubMed Web of Science ®Google Scholar
• Yao, Y., et al., 2018. Losartan alleviates renal fibrosis and inhibits endothelial-to-mesenchymal transition (EMT) under high-fat diet-induced hyperglycemia. Frontiers in Pharmacology, 9, 1213.
   PubMed Web of Science ®Google Scholar
• Yi, H., et al., 2017. LincRNA-Gm4419 knockdown ameliorates NF-kappaB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. Cell Death Disease, 8 (2), e2583.
   PubMed Web of Science ®Google Scholar
• Zelmanovitz, T., et al., 2009. Diabetic nephropathy. Diabetology and Metabolic Syndrome, 1 (1), 10.
   PubMed Web of Science ®Google Scholar
• Zhu, X., et al., 2015. Mangiferin attenuates renal fibrosis through down-regulation of osteopontin in diabetic rats. Phytotherapy Research, 29 (2), 295–302.
   PubMed Web of Science ®Google Scholar
• Zhu, X., et al., 2018. Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats. Journal of Cellular Biochemistry, 119 (1), 926–937.
   PubMed Web of Science ®Google Scholar
• Ziyadeh, F.N., and Wolf, G., 2008. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Current Diabetes Reviews, 4 (1), 39–45.
   PubMedGoogle Scholar
• Zou, X.Z., et al., 2017. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. European Journal of Pharmacology, 796, 190–206.
   PubMed Web of Science ®Google Scholar